Evidence map›Paper›PMID 36768504›Full record

ArticleInternational journal of molecular sciences2023

Utilizing the

Zsófia Garádi, András Tóth, Tamás Gáti, András Dancsó, Szabolcs Béni

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Automated, targeted, NMR spectral profiling of human breast milk.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zsófia GarádiDepartment of Pharmacognosy, Semmelweis University, Üllői út. 26, H-1085 Budapest, Hungary.ORCID 0000-0002-0152-2746
András TóthDepartment of Pharmacognosy, Semmelweis University, Üllői út. 26, H-1085 Budapest, Hungary.
Tamás GátiServier Research Institute of Medicinal Chemistry (SRIMC), Záhony utca 7, H-1031 Budapest, Hungary.
András DancsóDirectorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, H-1475 Budapest, Hungary.ORCID 0000-0001-8460-217X
Szabolcs BéniDepartment of Pharmacognosy, Semmelweis University, Üllői út. 26, H-1085 Budapest, Hungary.ORCID 0000-0001-7056-6825

Funding

Ministry of Innovation and Technology, Hungary KDP-1007075
6 · The paper itself

Abstract

Human milk oligosaccharides (HMOs) are structurally complex unconjugated glycans that are the third largest solid fraction in human milk after lactose and lipids. HMOs are in the forefront of research since they have been proven to possess beneficial health effects, especially on breast-fed neonates. Although HMO research is a trending topic nowadays, readily available analytical methods suitable for the routine investigation of HMOs are still incomplete. NMR spectroscopy provides detailed structural information that can be used to indicate subtle structural differences, particularly for isomeric carbohydrates. Herein, we propose an NMR-based method to identify the major isomeric HMOs containing GlcNAc and/or Neu5Ac building blocks utilizing their amide functionality. Experimental conditions were optimized (H

Indexed as

Breast FeedingMilk, HumanFemaleHumansInfantInfant, NewbornIsomerismMagnetic Resonance SpectroscopyOligosaccharidesOligosaccharides1H-15N HSQC-TOCSYamino-sugarcarbohydrate analysisGlcNAcHMON-acetylNMR resonance assignment

Identifiers

PMID36768504
PMCPMC9917050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.